Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$284K Buy
8,298
+1,637
+25% +$58.9K 0.01% 466
2024
Q3
$275K Sell
6,661
-530
-7% -$21.7K 0.01% 479
2024
Q2
$280K Sell
7,191
-546
-7% -$23K 0.01% 462
2024
Q1
$335K Buy
7,737
+165
+2% +$6.8K 0.02% 435
2023
Q4
$283K Buy
+7,572
New +$272K 0.01% 458
2021
Q3
Sell
-7,977
Closed -$411K 312
2021
Q2
$411K Buy
7,977
+1,055
+15% +$50.7K 0.03% 191
2021
Q1
$309K Buy
6,922
+214
+3% +$9.71K 0.03% 231
2020
Q4
$309K Sell
6,708
-1,912
-22% -$87.8K 0.03% 219
2020
Q3
$406K Sell
8,620
-1,322
-13% -$66.2K 0.04% 162
2020
Q2
$507K Buy
9,942
+360
+4% +$18.5K 0.05% 133
2020
Q1
$454K Buy
9,582
+4,344
+83% +$232K 0.06% 122
2019
Q4
$308K Buy
5,238
+482
+10% +$26.8K 0.03% 183
2019
Q3
$254K Buy
4,756
+12
+0.3% +$617 0.03% 181
2019
Q2
$237K Buy
4,744
+246
+5% +$12.3K 0.03% 184
2019
Q1
$235K Buy
+4,498
New +$225K 0.02% 189
2018
Q4
Sell
-4,294
Closed -$216K 209
2018
Q3
$216K Sell
4,294
-155
-3% -$7.88K 0.02% 185
2018
Q2
$224K Buy
4,449
+264
+6% +$13.3K 0.02% 289
2018
Q1
$204K Buy
+4,185
New +$195K 0.02% 291

Other funds holding GSK

Lake Street Advisors Group's GSK Position: Q4 2024 in Review

Lake Street Advisors Group increased its GSK (GSK) stake by 25% in Q4 2024, buying an estimated $58.9K and bringing the position to 8,298 shares worth $284K. The position accounts for 0.01% of the portfolio, ranked #466.

Lake Street Advisors Group first reported a position in GSK in Q1 2018 and has held it in 18 quarters since. The position peaked at $507K in Q2 2020. 849 funds tracked by Wall St. Rank hold GSK as of Q4 2024.

  • Lake Street Advisors Group held 8,298 shares of GSK worth $284K as of Q4 2024.
  • Lake Street Advisors Group bought 1,637 GSK shares in Q4 2024, an estimated $58.9K.
  • GSK made up 0.01% of Lake Street Advisors Group's portfolio in Q4 2024, its #466 holding.
  • Lake Street Advisors Group first reported a position in GSK in Q1 2018 and has held it in 18 quarters since.
  • Lake Street Advisors Group's GSK position peaked at $507K in Q2 2020.
  • 849 funds tracked by Wall St. Rank held GSK as of Q4 2024.

Based on Lake Street Advisors Group's 13F filing for Q4 2024, filed 4 Feb 2025.